Qinghui Liannuo

About:

Qinghui Liannuo is a biotechnology company engaged in the development of innovative immunological drugs.

Website: http://www.unicetbio.com

Top Investors: Highlight Capital, Longpan Investment, Zhongguancun Collaborative Innovation Fund

Description:

Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory and recurrent solid tumors and hematomas.

Total Funding Amount:

100M CNY

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2018-09-01

Contact Email:

info(AT)unicetbio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-11-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai